ACTRN12615000071527
Completed
Phase 4
Testosterone for Androgen Deficiency-Like Symptoms: A three phase, placebo-controlled, double-blind crossover study for males 40 years or older who believe they have androgen-like deficiency to assess whether testosterone gel treatment is superior to a placebo gel.
Department of Andrology, Concord Repatriation General Hospital0 sites40 target enrollmentJanuary 27, 2015
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Andrology, Concord Repatriation General Hospital
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men aged 40 years or older
- •Believed to have androgen deficiency (AD)
- •Symptoms consistent with AD (according to US clinical guidelines)
- •Provides written, informed consent and is willing to comply with study requirements
Exclusion Criteria
- •Pathologically\-based AD
- •Major chronic illness causing serious disability or with life expectancy less then 2 years in the opinion of the investigator
- •Major cardiovascular event (new or worsened angina, infarction, angioplasty, uncontrolled arrhythmia or hypertension) within the last 6 months
- •Contraindication to testosterone including prostate or breast cancer.
- •History of androgen or other drug abuse within last year.
- •History of HIV or viral hepatitis.
- •Skin disease that may interfere with transdermal drug administration.
- •History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements.
- •Regular use of medications that interfere with absorption, metabolism or action of testosterone and may require dosage change during the study.
- •Haematocrit over 0\.50 or history of polycythaemia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Treatment of Testosterone deficiency in men with Sleep Apnoea Syndrome utilising Nebido therapy.EUCTR2008-001459-23-GBikolai Sleep Monitoring Clinic
Active, not recruiting
Not Applicable
Prevalence Of Testosterone Deficiency In Patients With Chronic Obstructive Pulmonary Disease In King Chulalongkorn Memorial HospitalPrevalence of testosterone deficiency in male COPD patients in King Chulalongkorn Memorial HospitalChronic obstructive pulmonary diseaseTestosterone deficiencyTCTR20190301003Ratchadapisek Sompoch Endowment Fund, Faculty of Medicine, Chulalongkorn University130
Completed
Phase 2
Testosterone Therapy in Type 2 Diabetes Mellitus Patients with Erectile DysfunctioErectile dysfunction.Male erectile disorderF52.21IRCT20181106041575N1Research and technology deputy of Mashhad University of Medical Sciences66
Active, not recruiting
Phase 1
Does Testposterone improve the Pain Perception of Patients with Chronic Pain?Patient with persistent somatoform pain disorder (F45.40 or F45.41) should be included into the study.Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2016-000048-32-DERWTH Aachen University/CTC-A60
Not yet recruiting
Not Applicable
Testosterone insufficiency in human immunodeficiency virus (HIV) infected womeNL-OMON32221Academisch Medisch Centrum80